JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB20068

Anti-beta Amyloid 1-40 antibody [BDI350]

3

(3 Reviews)

|

(10 Publications)

Mouse Monoclonal Amyloid-beta precursor protein antibody. Suitable for WB and reacts with Synthetic peptide - Human samples. Cited in 10 publications. Immunogen corresponding to Synthetic Peptide within Human APP conjugated to Keyhole Limpet Haemocyanin.

View Alternative Names

A4, AD1, APP, Amyloid-beta precursor protein, ABPP, APPI, Alzheimer disease amyloid A4 protein homolog, Alzheimer disease amyloid protein, Amyloid precursor protein, Amyloid-beta (A4) precursor protein, Amyloid-beta A4 protein, Cerebral vascular amyloid peptide, PreA4, Protease nexin-II, CVAP, PN-II

1 Images
Western blot - Anti-beta Amyloid 1-40 antibody [BDI350] (AB20068)
  • WB

Unknown

Western blot - Anti-beta Amyloid 1-40 antibody [BDI350] (AB20068)

All lanes:

Western blot - Anti-beta Amyloid 1-40 antibody [BDI350] (ab20068) at 2 µg/mL

Lane 1:

Beta Amyloid peptide 1-40

Lane 2:

Beta Amyloid peptide 1-42

Lane 3:

Beta Amyloid peptide 1-43

Predicted band size: 86 kDa

true

Exposure time: 30s

Key facts

Host species

Mouse

Clonality

Monoclonal

Clone number

BDI350

Isotype

IgG1

Carrier free

No

Applications

WB

applications

Immunogen

Synthetic Peptide within Human APP conjugated to Keyhole Limpet Haemocyanin. The exact immunogen used to generate this antibody is proprietary information.

P05067

Specificity

Interacts with the C terminus of beta Amyloid 1-40. Does not cross react with beta Amyloid 1-42.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Synthetic peptide - Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "0.1-1 µg/mL", "WB-species-notes": "<p>1 μg/ml for AP / BCIP/ NBT(MTT) detection and 0.1 μg/ml for HRPO / ECL detection.</p>" } } }

Properties and storage information

Form
Lyophilized
Purification technique
Affinity purification Thiophilic Resin
Purification notes
Thiophilic adsorption and size exclusion chromatography.
Storage buffer
Preservative: 0.09% Sodium azide Constituents: PBS, 1% Sucrose, 0.5% Polyethylene glycol
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Beta Amyloid 1-40 also known as amyloid beta 40 is a peptide predominantly composed of 40 amino acids and it is a major product of amyloid precursor protein (APP) cleavage. Its molecular mass is approximately 4.3 kDa. This peptide is expressed in the brain tissue and cerebrospinal fluid. Beta amyloid engages in forming amyloid plaques which are deposits found most typically in the brain of patients with neurodegenerative conditions.
Biological function summary

Small soluble oligomers of beta amyloid interact with neuronal cells leading to synaptic dysfunction and cell death. Beta amyloid 1-40 molecules do not normally function in isolation; they often assemble into beta amyloid plaques a complex structure that can contribute to cellular anomalies. Amyloid beta production and its aggregation play parts in a process that disrupts neural communication impacting memory and learning processes.

Pathways

The amyloidogenic pathway involves beta amyloid where amyloid precursor protein (APP) is cleaved by beta-secretase and gamma-secretase to generate beta amyloid peptides including amyloid beta 40. This molecule is associated with the oxidation and inflammation pathways where it can interact with other proteins like presenilin. Presenilin is a part of the gamma-secretase complex that influences amyloid production thereby affecting the pathological aggregation process.

Beta amyloid 1-40 is closely linked to Alzheimer's disease a condition marked by cognitive decline and neural loss. The presence of amyloid plaques which are high in amyloid beta content is a characteristic marker of this disease. Furthermore beta amyloid is also associated with cerebral amyloid angiopathy a disorder where the peptide accumulates in the walls of the cerebral blood vessels. In this context tau protein another Alzheimer's-associated protein shows pathological changes influenced by the beta amyloid-induced plaque formation and contributes to neurofibrillary tangles formation.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Interaction between APP molecules on neighboring cells promotes synaptogenesis (PubMed : 25122912). Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(o) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1 (By similarity). By acting as a kinesin I membrane receptor, plays a role in axonal anterograde transport of cargo towards synapses in axons (PubMed : 17062754, PubMed : 23011729). Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV. The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Induces a AGER-dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons. Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1.. Amyloid-beta peptides are lipophilic metal chelators with metal-reducing activity. Bind transient metals such as copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to Cu(+) and Fe(2+), respectively. Amyloid-beta peptides bind to lipoproteins and apolipoproteins E and J in the CSF and to HDL particles in plasma, inhibiting metal-catalyzed oxidation of lipoproteins. Promotes both tau aggregation and TPK II-mediated phosphorylation. Interaction with overexpressed HADH2 leads to oxidative stress and neurotoxicity. Also binds GPC1 in lipid rafts.. Amyloid-beta protein 42. More effective reductant than amyloid-beta protein 40. May activate mononuclear phagocytes in the brain and elicit inflammatory responses.. Appicans elicit adhesion of neural cells to the extracellular matrix and may regulate neurite outgrowth in the brain.. The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis.
See full target information APP

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Neural regeneration research 17:2079-2088 PubMed35142700

2022

Aquaporin 4 deficiency eliminates the beneficial effects of voluntary exercise in a mouse model of Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Yun Liu,Pan-Pan Hu,Shuang Zhai,Wei-Xi Feng,Rui Zhang,Qian Li,Charles Marshall,Ming Xiao,Ting Wu

Nature communications 12:2185 PubMed33846335

2021

Therapeutic B-cell depletion reverses progression of Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Ki Kim,Xin Wang,Emeline Ragonnaud,Monica Bodogai,Tomer Illouz,Marisa DeLuca,Ross A McDevitt,Fedor Gusev,Eitan Okun,Evgeny Rogaev,Arya Biragyn

Journal of Alzheimer's disease : JAD 78:699-709 PubMed33016902

2020

Relationship Between Peripheral Transport Proteins and Plasma Amyloid-β in Patients with Alzheimer's Disease Were Different from Cognitively Normal Controls: A Propensity Score Matching Analysis.

Applications

Unspecified application

Species

Unspecified reactive species

Ling Gao,Jin Wang,Yu Jiang,Shan Wei,Suhang Shang,Chen Chen,Liangjun Dang,Kang Huo,Meiying Deng,Jingyi Wang,Qiumin Qu

PeerJ 7:e8219 PubMed31844591

2019

Icaritin, an inhibitor of beta-site amyloid cleaving enzyme-1, inhibits secretion of amyloid precursor protein in APP-PS1-HEK293 cells by impeding the amyloidogenic pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Fei Feng,Yuanyuan Li,Nanqu Huang,Yong Luo

Brain, behavior, and immunity 75:163-180 PubMed30389461

2018

Restoring microglial and astroglial homeostasis using DNA immunization in a Down Syndrome mouse model.

Applications

Unspecified application

Species

Unspecified reactive species

Tomer Illouz,Ravit Madar,Arya Biragyn,Eitan Okun

Brain pathology (Zurich, Switzerland) 29:176-192 PubMed30192999

2018

Deep cervical lymph node ligation aggravates AD-like pathology of APP/PS1 mice.

Applications

Unspecified application

Species

Unspecified reactive species

Linmei Wang,Yanli Zhang,Ying Zhao,Charles Marshall,Ting Wu,Ming Xiao

Theranostics 8:4210-4225 PubMed30128048

2018

Highly sensitive/selective 3D nanostructured immunoparticle-based interface on a multichannel sensor array for detecting amyloid-beta in Alzheimer's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Ta-Chung Liu,Yi-Chao Lee,Chiung-Yuan Ko,Ren-Shyan Liu,Chien-Chih Ke,Yu-Chun Lo,Pei-Sung Hong,Chao-Yi Chu,Ching-Wen Chang,Pu-Wei Wu,You-Yin Chen,San-Yuan Chen

PloS one 13:e0190350 PubMed29324783

2018

SIRT3 activator Honokiol attenuates β-Amyloid by modulating amyloidogenic pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Sindhu Ramesh,Manoj Govindarajulu,Tyler Lynd,Gwyneth Briggs,Danielle Adamek,Ellery Jones,Jake Heiner,Mohammed Majrashi,Timothy Moore,Rajesh Amin,Vishnu Suppiramaniam,Muralikrishnan Dhanasekaran

Journal of inorganic biochemistry 152:206-9 PubMed26213226

2015

Progressive inflammatory pathology in the retina of aluminum-fed 5xFAD transgenic mice.

Applications

Unspecified application

Species

Unspecified reactive species

A I Pogue,P Dua,J M Hill,W J Lukiw

Ultramicroscopy 109:923-8 PubMed19345496

2009

Electrical detection of beta-amyloid (1-40) using scanning tunneling microscopy.

Applications

Unspecified application

Species

Unspecified reactive species

Jin-Ho Lee,Da-Yeon Kang,Sang-Uk Kim,Cheol-Heon Yea,Byung-Keun Oh,Jeong-Woo Choi
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com